Lamprecht P, Gutzeit O, Csernok E, Gause A, Longombardo G, Zignego A L, Gross W L, Ferri C
Department of Rheumatology, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany.
Clin Exp Rheumatol. 2003 Nov-Dec;21(6 Suppl 32):S89-94.
To determine the prevalence, target antigens and clinical associations of antineutrophil cytoplasmic antibodies (ANCA) in chronic hepatitis C without extrahepatic manifestations and in chronic hepatitis C virus (HCV)-associated mixed cryoglobulinemia (MC) in two European centers.
50 sera from patients with chronic hepatitis C and 116 sera from HCV-associated MC were tested for cytoplasmic or perinuclear pattern (C-ANCA/P-ANCA) by indirect immunofluorescence test (IFT). ANCA target antigens were determined by enzyme-linked immunosorbent assay (ELISA).
Clinical characteristics of the patients were not different between the two centers. Cryoglobulinemic vasculitis (CV) was biopsy-proven in about 90% of the MC patients. Two patients with HCV-associated MC and 1 patient with chronic hepatitis C had a P-ANCA. A C-ANCA was detected in 1 patient with HCV-associated MC. Eight patients with a HCV-associated MC and 5 patients with chronic hepatitis C had an ANCA either directed against bactericidal/permeability increasing protein (BPI) or cathepsin G (CG). BPI- or CG-ANCA positivity was not associated with a more severe disease course. The C-ANCA titer followed disease activity in one C-ANCA positive HCV-associated MC patient. The subspecificity of the C-ANCA was not determinable in that patient.
Two new target antigens of ANCA have been identified in HCV-associated MC and chronic hepatitis C in this study. BPI-ANCA and GC-ANCA were present in about 10% of patients with HCV-associated MC or chronic hepatitis C. ELISA proved to be more sensitive in the detection of ANCA than IFT. The present study on chronic HCV infection adds to various reports on the induction of CG- and BPI-ANCA in chronic infections.
在两个欧洲中心,确定无肝外表现的慢性丙型肝炎以及慢性丙型肝炎病毒(HCV)相关混合性冷球蛋白血症(MC)中抗中性粒细胞胞浆抗体(ANCA)的患病率、靶抗原及临床关联。
采用间接免疫荧光试验(IFT)检测50例慢性丙型肝炎患者的血清以及116例HCV相关MC患者的血清,以确定其胞浆型或核周型(C-ANCA/P-ANCA)。通过酶联免疫吸附测定(ELISA)确定ANCA靶抗原。
两个中心患者的临床特征无差异。约90%的MC患者经活检证实有冷球蛋白血症性血管炎(CV)。2例HCV相关MC患者和1例慢性丙型肝炎患者有P-ANCA。1例HCV相关MC患者检测到C-ANCA。8例HCV相关MC患者和5例慢性丙型肝炎患者有针对杀菌/通透性增加蛋白(BPI)或组织蛋白酶G(CG)的ANCA。BPI或CG-ANCA阳性与更严重的病程无关。1例C-ANCA阳性的HCV相关MC患者中,C-ANCA滴度随疾病活动而变化。该患者中C-ANCA的亚特异性无法确定。
本研究在HCV相关MC和慢性丙型肝炎中鉴定出两种新的ANCA靶抗原。BPI-ANCA和GC-ANCA存在于约10%的HCV相关MC或慢性丙型肝炎患者中。ELISA在检测ANCA方面比IFT更敏感。本项关于慢性HCV感染的研究补充了各种关于慢性感染中CG-和BPI-ANCA诱导的报道。